About

Background

In 2019, the report of the Inter-Agency Coordination Group on AMR (IACG) to the UN Secretary-General (UNSG) recommended the establishment of an Independent Panel on Evidence for Action against AMR (IPEA) as part of AMR global governance structures, as well as a Global Leaders Group on AMR and the AMR Multistakeholder Partnership Platform, both of which have already been established. 

At the 79th Session of the UN General Assembly in September 2024, countries adopted the Political Declaration of the High-level Meeting on Antimicrobial Resistance. The Declaration invites the Quadripartite organizations to establish an IPEA in 2025 to facilitate the generation and use of multisectoral, scientific evidence to support Member States in efforts to tackle AMR. The Political Declaration further notes the need for an open and transparent consultation with all Member States and other relevant stakeholders on its composition, mandate, scope, and deliverables, making use of existing resources and avoiding duplication of on-going efforts. To ensure that the panel can begin operations by the end of 2025, the Quadripartite will develop a set of documents to underpin the establishment and operations of a strong and effective IPEA.  

Rationale for Establishing an IPEA

Effective policymaking relies on robust evidence, yet AMR data are often fragmented across sectors, making it challenging for policymakers to evaluate, prioritize and act on proven solutions. Additionally, significant evidence gaps limit progress and weaken the case for essential and sustainable funding and interventions. Independent panels illustrate the impact of objective, authoritative science-policy bodies in building global consensus and fostering action on complex issues. The IPEA's primary purpose would be to equip Member States with reliable evidence to guide informed policy and funding decisions and to promote high-impact interventions against AMR across diverse contexts.